The results showed that in high risk patients with T2D liraglutide reduced the risk of MACE by 13% (primary endpoint included cardiovascular death, non-fatal myocardial infarction (MI), and non-fatal stroke) ( In the ELIXA and the EXSCEL trials, GLP-1RAs (once daily lixisenatide and once weekly exenatide, respectively) didnt provide benefit in MACE reduction compared to placebo, but were non-inferior to placebo for the primary composite outcome of MACE
The adverse effects reported were consistent with whats already known about GLP-1 agonists
Symptoms like difficulty breathing, swelling of the face or throat, and severe dizziness require immediate medical attention
J Biol Chem 257:99099912 Mannervik B, Danielson UH (1988) Glutathione transferasesstructure and catalytic activity
"Sustained healthy lifestyle choices promote weight loss maintenance and blood sugar control." Keaveney's top strategies for maintaining blood sugar control and weight loss after semaglutide include: Regular exercise especially strength-building exercise Ample vegetables and lean protein Stress management to prevent slipping back into unhelpful habits 3